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Abstract.  During cardiac myogenesis, ventricular 
muscle cells lose the capacity to proliferate soon after 
birth.  It is unknown whether this developmental block 
to mitotic division and DNA replication might involve 
irreversible repression of the cellular oncogene c-myc. 
Ventricular myocytes from 2 d-old rats continued to 
differentiate in vitro during  15 d of mitogen with- 
drawal,  as shown by the formation of cross-striations, 
increased proportion of the muscle isoenzyme of crea- 
tine kinase,  stable expression of or-cardiac  actin and 
myosin heavy chain mRNAs, and appropriate down- 
regulation of a-skeletal actin mRNA. After mitogen 
withdrawal for 2 d,  serum evoked both DNA synthesis 
and mitotic division; after 7 d,  DNA replication was 
uncoupled from cell division;  after  15 d,  DNA synthe- 
sis itself was markedly attentuated.  These three dis- 
tinct phenotypic states resemble the sequential proper- 
ties of growth found in the neonatal rat heart in vivo. 
Despite failure to induce DNA replication or division 
after  15 d of mitogen withdrawal,  serum elicited both 
c-myc and ct-skeletal actin as found during hyper- 
trophy of the intact heart.  The results agree with 
previous evidence that one or more functional path- 
ways that transduce the effects of serum factors may 
persist in older cardiac muscle cells, and indicate that 
irreversible down-regulation of c-myc cannot be the 
basis for the loss of growth responses. 
I 
DENTIFYING the cellular mechanisms  that control car- 
diac muscle growth is essential to understanding  cardiac 
myocytes  failure  to regenerate  after injury,  as well as 
hypertrophy  triggered by a physiological load. Fundamental 
differences may distinguish cardiac development from that of 
skeletal  muscle cells or other  readily  accessible systems. 
First, proliferation  of skeletal myoblasts is mutually  exclu- 
sive  with activation  of muscle-specific  genes  (9,  29,  38), 
whereas cardiac myocytes synthesize  muscle-specific  pro- 
teins  and become contractile  while still proliferating  (35). 
Second,  formation  of binucleated  myocytes during  the loss 
of growth capacity in cardiac  muscle (karyokinesis  uncou- 
pled from cytokinesis) differs importantly  from assembly of 
multinucleate  myotubes via cell fusion (6). Third, adaptive 
growth  of cardiac  muscle involves enlargement  (hypertro- 
phy) and DNA synthesis  (nuclear  hyperplasia)  in pre-exist- 
ing muscle cells (26), while skeletal muscle growth is medi- 
ated in part by recruitment  of "satellite" precursor cells. Fi- 
nally, increased contractile  work induces  cardiac muscle to 
reexpress genes that encode "embryonic" contractile and cyto- 
solic proteins  (18, 41) but can accelerate the maturation  of 
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myosin heavy chain isoforms in skeletal muscle (19). These 
observations  suggest that cardiac myocytes have unique bio- 
logical features and that distinct molecular mechanisms  may 
control their proliferative growth as well as the onset and es- 
tablishment  of a differentiated cardiac phenotype.  However, 
the exact cellular and molecular mechanisms  that  regulate 
development  in cardiac  myocytes remain to be elucidated. 
Knowledge of the processes that regulate growth and dif- 
ferentiation has been expanded by the discovery that cellular 
oncogenes may encode peptide mitogens and their receptors 
or convey growth factor signals from the surface membrane 
to the nucleus  (reviewed in reference  38).  Intranuclear  on- 
cogene proteins  such as fos, erbA, and jun bind cis-acting 
regulatory  DNA  sequences and  may affect  cell  behavior 
directly.  The  impact  of growth  factors  on proliferation  is 
thought to require,  in particular,  the proto-oncogene,  c-myc 
(7). In quiescent skeletal muscle as in other lineages, c-myc 
gene expression is rapidly increased by growth factors (46); 
conversely, down-regulation  of c-myc is an early event dur- 
ing myogenic differentiation  (9, 40) which fails to occur in 
muscle cell lines that cannot differentiate  (32, 42). During 
normal  cardiac  development,  c-myc  becomes down-regu- 
lated in ventricular tissue (39) but can be elicited by interven- 
tions that provoke hypertrophic  growth in vivo and in vitro, 
such as aortic constriction  and norepinephrine,  respectively 
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poral relationships has been substantiated, at least in non- 
muscle cells, through the use of bacterially produced myc 
protein or deregulated myc genes as surrogates for growth 
factors (reviewed in reference 38) and by anti-myc antibodies 
(17) and anti-sense oligonucleotides (51) that block DNA 
replication or trigger differentiation. Although down-regu- 
lation of c-myc is not obligatory for muscle development, 
autonomous expression of c-myc can delay or partially in- 
hibit the myogenic phenotype (3, 40). In contrast, the viral 
myc gene can abolish differentiation of skeletal muscle cells, 
most likely by maintaining autonomous proliferation (12). 
DNA sequences recognized by myc are found at or near the 
initiation site of DNA replication (17). Recently, v-myc also 
was  shown to  impair  cardiac differentiation and produce 
cardiac rhabdomyosarcomas in avian embryos (37). 
Together,  these observations  suggest that c-myc is  inti- 
mately associated with cardiac muscle cell growth and raise 
the hypothesis that a block to mitogenic induction of c-myc 
might provide a basis for the age-dependent loss of cardiac 
growth capacity. As a first step to determine whether cardiac 
growth control involves developmental regulation of specific 
components of the machinery for growth factor signal trans- 
duction, we have isolated ventricular cardiac myocytes from 
2-d postnatal rats and examined their developmental proper- 
ties during 2 wk of mitogen withdrawal. The uncoupling of 
DNA replication from mitotic growth followed by attenua- 
tion of DNA synthesis, corresponded to the phases of cardiac 
growth found in neonatal ventricular muscle (6, 30). Cardiac 
myocytes which neither replicate DNA nor divide retained 
at least partial responsiveness to serum, as demonstrated by 
induction of c-myc and  the  "embryonic" a-skeletal  actin 
gene, as found after the transition to hypertrophic growth in 
vivo. 
Materials and Methods 
Cell Culture 
Primary cultures of cardiac myocytes were prepared from the ventricles of 
2-d-old Sprague-Dawley rats by 4 cycles of enzymatic digestion with gentle 
mechanical disaggregation. Cells were dissociated at 37°C and 40 rpm in 
Ca  2+- and Mg2+-free PBS, supplemented with  1%  glucose, 0.1% trypsin 
(TRL3), 0.1% collagenase (CLS), and 0.025%  DNase I (D; Worthington 
Biochemical Corp., Freehold, N J). After the final cycle of digestion, the 
dissociated cells were pooled in medium (DME; Ham's nutrient mixture 
F12[Gibco  Laboratories,  Grand Island, NYI, 1:1, adjusted to 17 O.M Hepes, 
pH 7.4,  3 I.tM NaHCO3,  2  I.tM L-glutamine,  and 50 ltg/ml  -~ gentamicin) 
supplemented with 10% heat-inactivated FBS (HyClone, Logan, UT). The 
cell population was enriched for cardiac myocytes and partially depleted of 
cardiac mesenchymal cells by differential adhesiveness. The residual nonat- 
tached cells were plated at "o105 cells/cm  2 on polystyrene culture dishes 
treated with 0.1% gelatin (ICN Biochemicals Inc., Irvine, CA). After 12- 
16 h, the cells were maintained in serum-free medium supplemented with 
1  tag/ml insulin,  5  I.tg/ml transferrin,  1  nM  LiCI,  1 nM  Na2SeO4,  25 
~tg/ml ascorbic acid, and 0.1 nM thyroxine. From day 4 onward, the me- 
dium also contained 0.5% calf serum (HyClone) and was replaced every 
3 d. Primary cultures enriched for cardiac mesenchymal cells were obtained 
from the rapidly adherent fraction of ventricular cells. 
cDNA Probes 
To quantitate steady-state levels of c-myc mRNA, a 2.5-kbp Xbal-Hind III 
restriction fragment was  isolated  from  plasmid  pSVc-myc-1,  containing 
exons 2 and 3 of murine c-myc (20). Glyceraldehyde-3-phosphate  dehydro- 
genase (gad) ~ mRNA was measured using the 1.65-kbp  Hhal restriction 
fragment of pGAD-28 (8). DNA fragments were labeled with a-nP-dCTP 
(3,000 Ci/nunol-~; Amersham Corp., Arlington Heights, IL) to !-5 x  109 
cpm/I.tg  by  the random primer method (13).  Synthetic oligonucleotides 
used to examine rat a-cardiac and a-skeletal actin expression corresponded 
to  the  specific 3'  untranslated  sequences 83-102  (25)  and  48-67  (43), 
respectively. Probes were labeled at the 5' end with ¢t-32p-ATP using T4 
polynucleotide kinase, to a  specific activity of 4-6  x  108 cpm/p,g (24). 
Northern Blot Hybridization 
Total cellular RNA was isolated, size fractionated by formaldehyde-agarose 
gel electrophoresis (10  i,  tg/lane),  and transferred to nitrocellulose filters 
as previously described (32).  For myc and gad cDNA probes, blots were 
washed in 2x SSC, 0.5% SDS for 45 min at room temperature and in 0.Ix 
SSC, 0.1% SDS for 90 min at 60°C. For oligonucleotide probes, blots were 
washed for45 min in 5x SSC at room temperature and for 90 s in 5x SSC 
at 55°C. Blots were exposed to Kodak XAR-2 film at -70°C with intensify- 
ing screens (Lightning-Plus; DuPont Co., Wilmington, DE) and were quan- 
titated by scanning densitometry. Band intensity was linear with respect to 
RNA concentration. 
Results 
Mitogen Withdrawal Elicits Differentiated 
Structural and Biochemical Properties in Cultured 
Ventricular Myocytes 
Cardiac cells formed a functional syncytium, as indicated by 
synchronous spontaneous contractions, from day 2 onward. 
By days 2 and 3, the contractile myocytes developed a charac- 
teristic morphology consisting of a  coarse granular cyto- 
plasm with dense inclusions and a dense round nucleus. By 
the criteria of morphology and spontaneous contraction, the 
ventricular myocytes were readily distinguished from non- 
muscle cells (<10%), which exhibited a pale cytoplasm, thin 
filopodia, and a larger, ellipsoid nucleus bounded by a thin 
nuclear membrane. These respective properties were main- 
tained through day  15  of mitogen withdrawal (cf.  5,  44). 
Cross-striations  and  binucleated  ventricular  muscle  cells 
were found from day 6 or 7 onward. To examine whether the 
cardiac cells were stably differentiated after mitogen with- 
drawal, the distribution of CK isoenzymes was analyzed at 
day 2, 7, and 15 (ll). The proportion of the "muscle" homo- 
dimer (MM) increased progressively, from 53 % at day 2 to 
59% at day 7, and, finally, to 70% at day 16 (Fig.  l, A-C). 
In contrast, the proportion of the "brain" homodimer (BB), 
which is relatively abundant both in immature cardiac myo- 
cytes and in nonmuscle cells (Fig.  1 D),  was initially ex- 
pressed at 11%  and was stably maintained. 
To define more completely the extent of differentiation 
in this in vitro model, expression of representative devel- 
opmentally regulated sarcomeric proteins was analyzed by 
Northern hybridization. As shown in Fig. 2, steady-state lev- 
els of a-MHC mRNA did not deteriorate during 15 d of se- 
rum withdrawal (cf. 28,  52).  In aggrement with its persis- 
tence at 14 d of age in vivo (22),  I3-MHC mRNA also was 
expressed in the oldest cells examined here.  As discussed 
more fully below, basal expression of a-cardiac and ct-skele- 
tal actin mRNA during 2 wk in monolayer culture was, like- 
wise, appropriate to the cells' developmental stage. 
1. Abbreviations  used in this paper:  CK, creatine kinase; gad, glyceralde- 
hyde 3-phosphate dehydrogenase; MHC, myosin heavy chain. 
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Figure 1.  Distribution  of CK  isoen- 
zymes in cultured  cardiac  myocytes. 
The  dimeric  isoenzymes (MM, MB, 
and BB) of creatine kinase  were ana- 
lyzed  by  agarose  electrophoresis  of 
cell  lysates  of cardiac  myocytes  cul- 
tured in differentiation medium for (A) 
2, (B) 7, or (C)  15 d. The percentage 
of total  CK activity comprising each 
isoenzyme is shown below the respec- 
tive panel  of the figure.  (D) Distribu- 
tion of CK isoenzymes in cultures enriched for cardiac mesenchymal cells after mitogen withdrawal for 7 d. CK isoenzymes were separated 
by agarose gel  electrophoresis  and measured by scanning  fluorimetry of the creatine  phosphate-dependent  fluorescence generated  as 
NADPH, using  the coupled enzyme method of Rosalki  (34). 
Three Phases of Cardiac Growth Identified In Vitro 
Correspond to the Postnatal Development Observed in 
Intact Ventricular Muscle 
To determine whether a time-dependent  loss of growth ca- 
pacity could be observed in isolated cardiac myocytes in the 
absence of hemodynamic and neurohumoral changes, quies- 
cent ventricular  muscle  cells  were  challenged with  serum 
mitogens  (20%  FBS)  after  2,  7,  or  15  d  in differentiating 
medium,  and were examined for cell number and  [3H]thy- 
midine incorporation into DNA (Fig.  3).  Initially, after 2 d 
of mitogen withdrawal,  serum mitogens could provoke both 
DNA replication and subsequent mitosis (left graph).  After 
the  mitogenic  challenge,  [3H]thymidine  incorporation  in- 
creased within  12 h and reached a peak at 21 h, after which 
cytokinesis occurred: the cell population increased  1.8-fold 
within 30 h. In contrast, after 7 d in differentiating medium, 
DNA synthesis became uncoupled from mitotic division: no 
increase in cell number was found, although DNA synthesis 
was  evoked  by  serum  to  almost  the  same  extent  (middle 
graph).  Even the capacity to replicate DNA in response to 
serum mitogens was markedly attenuated in ventricular myo- 
cytes that had been cultured  in differentiating  medium  for 
15 d (right graph). The incorporation of [3H]thymidine into 
DNA was approximately one-fifth of that observed at day 2. 
Figure 2. Expression  of ct- and 
13-MHC mRNA at 2 and 15 d 
of  serum  withdrawal.  Total 
cellular RNA was isolated  at 
the  intervals  indicated,  and 
the  levels  of a- and  13-MHC 
mRNAs were determined  by 
Northern blot hybridization to 
32p-labeled synthetic  oligonu- 
cleotide  probes  (14). As  the 
specific activities and exposure 
times for autoradiography  dif- 
fered,  the  signal  intensities 
are not intended  to represent 
the relative  abundance of the 
two transcripts.  Levels of gad 
mRNA  did  not  change  sig- 
nificantly.  Control  14-d  rat 
cardiac mRNA is shown at the 
left. 
No secondary peak of thymidine incorporation was detected 
to indicate prolongation of the G1  phase of the cell  cycle, 
even with observation for up to 48 h  after serum addition. 
c-myc mRNA Remains Inducible in Cardiac Myocytes 
that Cannot Replicate DNA or Divide in Response to 
Serum Mitogens 
To examine the hypothesis that irreversible repression of the 
c-myc gene in ventricular myocytes might provide a molecu- 
lar basis for the age-dependent loss of cardiac growth capac- 
ity,  the inducibility  of c-myc mRNA in response to serum 
mitogens was determined in cardiac myocytes at each of the 
three sequential stages of growth response described above. 
In cardiac myocytes cultured for 2 d, which respond to serum 
with both  DNA synthesis  and proliferation,  c-myc mRNA 
was induced by mitogens within 1 h, reached maximal induc- 
tion at '~2 h, and returned to baseline levels between 12 and 
24 h after serum addition (Fig. 4; data at 0.5-2 h, not shown), 
as  in other  myogenic cells  (9,  46).  Despite  the  sequential 
block to cytokinesis and even DNA synthesis in cardiac myo- 
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Figure 3. The age dependence of [3H]thymidine incorporation and 
cell proliferation after exposure of  quiescent cardiac myocytes to se- 
rum mitogens identifies three distinct  stages of cardiac growth ca- 
pacity. Cardiac myocytes were cultured  in differentiation  medium 
for (left  graph) 2, (center  graph) 7, or (right graph) 15 d and were 
then transferred  to medium containing  20%  FBS at time 0.  (e) 
Acid-insoluble  incorporation of [3H]thymidine was determined af- 
ter incubation for 60 min at 37°C in serum-free medium containing 
3  IxCi/ml [SH]thymidine.  (A)  Cell  number  was  determined  in 
duplicate  using  a hemocytometer.  Similar  data  were  observed in 
each of three  independent  experiments. 
Ueno  et al. Differentiation  of Cardiac Myocytes  In  Vitro  1913 Figure 4. Irreversible  repression  ofc-myc is not required for the loss of cardiac growth capacity. Cultured cardiac myocytes were maintained 
in differentiation  medium for 2, 7, or 15 d and were then transferred  to growth medium containing  20%  FBS. Total cellular  RNA was 
isolated after serum stimulation  for the intervals  shown above each lane, and the level of c-myc mRNA was determined  by Northern blot 
hybridization.  The positions  of 28S and  18S ribosomal RNA are indicated. 
cytes that had been cultured in differentiating medium for 7 
or 15 d, respectively, c-myc also was induced within 2  h  in 
cardiac cultures that had lost one or both growth responses 
(cf. 9, 33). However, the expression of c-myc was not identi- 
cal in older cells. With increasing duration of mitogen with- 
drawal,  basal levels of c-myc mRNA estimated by scanning 
densitometry decreased to 0.5 of control, and the level of in- 
duction (compared with quiescent cells) diminished partially 
from 4.25-fold to 3.5-fold at  15 d.  In addition,  the kinetics 
of myc induction differed in ventricular myocytes maintained 
in culture for 15 d; maximal expression of c-myc was delayed 
(maximal at 24 h of serum stimulation)  and was sustained. 
To address the possibility that c-myc might be confined to 
a residual fraction of contaminating mesenchymal cells, the 
induction  of c-myc  mRNA  was  determined  separately  in 
myocyte and mesenchymal cell cultures that had been incu- 
bated  for 7  d  under  identical  conditions  of mitogen with- 
drawal (Fig. 5). Serum induced c-myc mRNA to comparable 
levels (per microgram of RNA) in cardiac myocyte and mes- 
enchymal cell cultures. For reference, the cultures also were 
stimulated  with the a~-adrenergic agonist,  norepinephrine; 
in agreement with previous results (48),  norepinephrine in- 
duced c-myc mRNA in ventricular myocytes, whereas cardi- 
ac fibroblasts did not respond.  Since myocyte-enriched and 
myocyte-depleted cultures that were stimulated with serum 
contained  levels  of c-myc  mRNA  similar  to  one  another, 
c-myc mRNA in myocyte cultures must largely be expressed 
in  the  dominant  population  of cardiac  myocytes  and  not 
merely in the relatively  few fibroblastic cells. 
Serum Regulates a-Actin Gene Expression in 
Ventricular Muscle Cells Even after the Loss of 
Growth Responses 
To obtain independent evidence for the persistence of serum 
effects on gene expression at each of the phenotypic stages 
identified above, we investigated regulation of the a-cardiac 
Figure 5. Serum induction  of c-myc mRNA in ventricular  myocyte 
cultures  cannot be  accounted for by cardiac  mesenchymal cells 
alone.  Myocyte-enriched and  myocyte-depleted  ("fibroblast")  cul- 
tures prepared as described in Materials  and Methods  were main- 
tained in differentiation  medium for 7 d and were then treated with 
growth  medium  containing  20%  FBS  for 2  h  (serum)  or with 
differentiation  medium containing  10 ~tM norepinephrine  for 1 h 
(NE). Total cellular RNA was isolated, and expression ofc-myc was 
measured by Northern blot hybridization.  The positions of 28S and 
18S ribosomal RNA are  shown.  The relative  abundance of mck 
mRNA in myocyte-enriched  and fibroblast cultures  also is shown. 
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and  a-skeletal  actin  mRNA  in 
ventricular  myocytes during  dif- 
ferentiation  elicited  by  mitogen 
withdrawal and during serum stim- 
ulation. The cultures were main- 
tained in differentiation medium 
for 2,  7, or  15 d and were then 
transferred  to  growth  medium 
containing 20%  FBS. The levels 
of a-cardiac and a-skeletal  actin 
mRNAs were determined by Nor- 
thern  blot  hybridization  to  32p_ 
labeled synthetic oligonucleotide 
probes, as described in Materials 
and  Methods  and  the  legend to 
Fig. 2. 
and a-skeletal actin genes, since analysis of the embryonic/ 
neonatal isoform is not confounded by its presence in fibro- 
blastic cells (like bck) or by fluctuations in thyroid hormone 
level (like I]-MHC). Adult (a-cardiac) actin mRNA already 
was expressed in cultured ventricular myocytes after 2 d  in 
differentiating  medium,  and  continued  to  be expressed at 
similar levels for at least 2 wk without evidence of dediffer- 
entiation (Fig. 6). By contrast, a-skeletal actin mRNA coex- 
isted with a-cardiac actin mRNA after 2 d in differentiation 
medium but subsequently declined by at least 90 %, corre- 
sponding to actin expression in the normal postnatal heart. 
The abundance of gad mRNA, which does not fluctuate dur- 
ing cardiac or skeletal muscle differentiation (32, 39) and is 
used to detect inconsistent mRNA loading and transfer, did 
not vary. Cardiac mesenchymal cells expressed neither a-ac- 
tin mRNA species (data not shown). 
To determine whether ¢t-actin mRNA expression could be 
modulated by serum factors in ventricular muscle cells that 
no longer proliferate in the presence of serum, the abundance 
of a-cardiac and a-skeletal actin mRNA was analyzed after 
a mitogenic challenge, after differentiation for 2, 7, or 15 d 
(Fig. 6). 24 h after exposure to 20% FBS, the level of both 
a-cardiac and a-skeletal actin mRNAs was significantly de- 
creased in ventricular myocytes that had been subjected to 
mitogen withdrawal for 2 or 7 d. Compared to mRNA abun- 
dance before adding serum, a-skeletal actin levels decreased 
to 0.48 and 0.71 of control, at 2 and 7 d, respectively. Corre- 
sponding values for a-skeletal actin were 0.27 and 0.22. Con- 
trasting results were obtained in ventricular myocytes that 
had been maintained for 15 d in differentiation medium and 
lost the ability to replicate DNA.  Serum reduced the abun- 
dance of a-cardiac actin mRNA to 0.76 of control at 24 h, 
but  produced  at  least a  2.4-fold  increase  in  levels of the 
a-skeletal actin transcript (Fig.  6).  Fig.  7  summarizes the 
results of scanning  densitometry for serum modulation of 
a-cardiac and a-skeletal actin mRNA, together with c-myc, 
during each of the three phenotypic states. 
Discussion 
Several lines of inquiry indicate that the regulation of prolif- 
erative growth and differentiation in cardiac myocytes may 
possess unique  biological  features whose  molecular basis 
is largely unexplored.  However, successful investigation of 
atrial or ventricular cardiac muscle cells has been compli- 
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Figure 7. Mitogen withdrawal alters responses to mitogen challenge 
in cultured cardiac myocytes. The figure summarizes the results of 
Northern blot hybridization shown in Figs. 4 and 6, as analyzed by 
scanning  densitometry.  For each  species  of mRNA assayed,  all 
values are normalized to the abundance observed in 2-d cultures at 
Oh. 
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ity but perhaps more importantly by inappropriate expres- 
sion  of embryonic protein isoforms.  Although  the use of 
mitogen withdrawal to promote the purity of cardiac muscle 
cells in culture is known (5, 28, 45), relatively little informa- 
tion has been available to establish whether mitogen with- 
drawal might also be sufficient to ensure the differentiated 
phenotype in cultured ventricular muscle cells. Noteworthy 
features of the in vitro preparation reported here include: (a) 
quiescence of the  ventricular myocytes in  the absence of 
exogenous growth factors; (b) spontaneous contraction main- 
tained for 2 wk; (c) assembly of striations from day 6 on- 
ward; (d) a progressive increase in the fraction of muscle- 
specific subunits of CK; (e) stable expression of ~t-cardiac 
actin and MHC mRNAs for at least 15 d; and (f) appropri- 
ate down-regulation of the ~t-skeletal actin transcript. Thus, 
mitogen withdrawal was sufficient to ensure the developmen- 
tally accurate expression of cardiac-specific genes for at least 
15 d and prevented the de-differentiation of ventricular myo- 
cytes which has been associated with cell culture in the pres- 
ence of high concentrations of serum (cf. 28, 50, 52). Since 
abundance  of ct-skeletal  actin  mRNA  normally  is  down- 
regulated between 15 and 30 d of age (25), the findings sug- 
gest that maturation of ventricular myocytes not only was 
maintained,  but also  progressed appropriately during  the 
period of mitogen withdrawal.  Simpson and co-workers iden- 
tified the cross-striated morphology as an important indica- 
tor of  differentiated structure, and regarded formation of stri- 
ations in cultured ventricular muscle cells as representing a 
return to the original state of differentiation that had existed 
in vivo (44). Our results are consistent with the additional 
implication that mitogen withdrawal can enable the progres- 
sion of developmentally regulated properties beyond the state 
found in ventricular myocytes at the time of their isolation. 
Three sequential phases of growth control were identified 
in  the  model  during  progressively increasing  intervals of 
mitogen withdrawal. These correspond to the three charac- 
teristic phases of growth observed in the perinatal rat heart 
in vivo (6, 30), indicated by the uncoupling of DNA synthesis 
from mitotic division as found in neonatal ventricular mus- 
cle. Little or no mitotic division and DNA replication are 
found in ventricular myocytes older than 3 wk of age, even 
under conditions of hemodynamic load that trigger hyper- 
trophic growth  (reviewed in  reference 27).  As  previously 
suggested in chick cardiac myocytes (4), diminished growth 
responsiveness in rat cardiac muscle cells more closely re- 
sembled irreversible withdrawal from the cell cycle in skele- 
tal muscle (29) than senescence in fibroblastic cells, whose 
decreased growth capacity involves, instead, increased dura- 
tion of the G1 phase of the cell cycle (33). Taken together, 
the findings indicate that developmentally regulated proper- 
ties of cardiac muscle can be accurately expressed in vitro, 
and the culture system characterized here functions as a suit- 
able model with which to investigate the underlying molecu- 
lar processes that control cardiac growth and differentiation. 
The hypothesis that expression of the cellular oncogene 
c-myc might be linked to the control of growth in ventricular 
muscle cells was suggested by several independent forms of 
evidence cited above. Our results contrast with the simple 
correlation between activation of c-myc and either DNA syn- 
thesis or cell proliferation, and should be viewed in the con- 
text of an increasing number of observations that c-myc ex- 
pression by itself is neither sufficient nor necessary to evoke 
the phenotypic changes prompted by various growth signals 
(reviewed in references 38, 40). Our findings described here 
extend the recent report that serum mitogens can provoke 
c-myc expression even in L6E9-B skeletal muscle cells that 
have undergone terminal differentiation (9).  Since postmi- 
totic myotubes also fail to respond in most respects to trans- 
forming growth factor 13, the most potent known regulator of 
muscle differentiation, despite the  presence of functional 
receptors for the peptide (23), the failure of c-myc induction 
to affect terminally differentiated skeletal muscle cells cannot 
necessarily be extrapolated to other myogenic systems. How- 
ever, the kinetics of c-myc expression were rapid and tran- 
sient in both L6E9-B myoblasts and myotubes (and in cardiac 
myocytes cultured for 2 d) whereas, after mitogen withdrawal 
for 15 d, up-regulation of c-myc in ventricular myocytes was 
delayed and sustained. Delayed accumulation of c-myc also 
has been observed during growth mediated by autocrine fac- 
tors (21). 
The results of our experiments also show that ventricular 
muscle cells that do not replicate DNA can respond to serum 
with induction of a-skeletal actin mRNA.  This finding is 
consistent with the known ability of serum to provoke other 
aspects of hypertrophy, such as increased cell volume and 
protein (44).  Although ~t-skeletal  actin is abundant in the 
embryonic or newborn heart, and ~t-cardiac  actin is found, 
analogously, in immature skeletal muscle, the relationship 
between these two genes  is  not reciprocal in  most other 
respects. For example, primer extension studies have shown 
that equivalent levels of the two transcripts coexist in early 
embryonic limb and cardiac muscle (31), and in situ hybrid- 
ization has recently demonstrated that induction of ~t-cardiac 
actin precedes or-skeletal  actin expression in both lineages 
(36). Furthermore, numerous states and interventions exist 
that regulate both actin genes in tandem. In skeletal muscle, 
both ~t-actin genes are transcriptionally inactive during pro- 
liferation (1, 29), are induced at low levels in confluent cells 
even before serum withdrawal (1), are blocked by transform- 
ing growth factor 13 (23) or an activated c-H-ms gene (32), 
and are down-regulated by metalloendoprotease inhibitors 
(10) even in myotubes (15).  In this context, suppression of 
both tt-actin genes by serum in ventricular myocytes at 2 d 
of mitogen withdrawal resembles the coordinate inhibition of 
both  sarcomeric actins  in differentiated skeletal myocytes 
that have not undergone the transition to terminal differentia- 
tion (29). 
Contrasting conditions also have been demonstrated that 
regulate a-skeletal and ~t-cardiac actin independently. Medi- 
um containing <150 IxM Ca  2÷ specifically blocks ~t-skeletal 
actin induction in cultured chick myocytes (15). Conversely, 
L6E9 myoblasts fail to express ~t-cardiac  actin, despite ap- 
propriate induction of ct-skeletal  actin (16).  In rat cardiac 
muscle, aortic constriction and norepinephrine each provoke 
~10-fold induction of ct-skeletal actin mRNA, with no effect 
on the ~t-cardiac actin gene or modest stimulation (2, 14, 18, 
41). Thus, although the relationship seen here between loss 
of growth capacity and control of a tissue-specific gene is 
distinct from terminal  differentiation observed in  skeletal 
muscle, the results in vitro are consistent with what is known 
to occur in adult cardiac muscle subjected to physiological 
growth signals. Hypertrophic growth and altered actin gene 
expression prompted by aortic constriction or norepineph- 
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spite intriguing similarities between the responses of cardiac 
muscle to a hemodynamic load in vivo vs. adrenergic stimu- 
lation or serum  mitogens  in vitro,  it is unknown whether 
these contrasting growth signals are coupled to cardiac mass 
and embryonic gene expression through related transduction 
pathways. 
Serum contains a number of molecules other than peptide 
growth factors such as catecholamines which might, in prin- 
ciple,  account for a portion of the results described  here. 
However,  the concentration of norepinephrine in medium 
supplemented  with 20%  FBS  (~60  pM;  reference  45)  is 
three orders of magnitude below the minimal concentration 
required  to  activate  a-skeletal  actin  mRNA  (2).  Further- 
more,  thyroid  hormone  effects  the  expression  of myosin 
heavy chain genes,  but does not induce a  transition from 
a-cardiac  to  a-skeletal  actin  (14).  Serum  is  a  potent but 
crude growth agonist that exerts striking, bifunctional effects 
on a-skeletal actin mRNA (inhibition at a stage when it is 
normally expressed; induction at a stage when it is normally 
silent).  The ability of single growth factors to exert multi- 
functional effects,  depending on the state of differentiation, 
has been recently reviewed (47). While the issue of identify- 
ing the exact serum molecules that regulate cardiac myocyte 
growth and gene expression cannot be resolved by the data 
presented here; this in vitro model provides a basis for such 
studies. Although the potential involvement of innervation, 
cell work, and constituents of the extracellular matrix have 
not yet been  resolved,  it  seems  likely  that mitogen with- 
drawal, by itself, can overcome certain of the obstacles that 
have precluded a molecular dissection of cardiac myogenesis 
in vitro. 
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